VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
VYNE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
VYNEVYNE Therapeutics Inc.
$39.50$26M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksVYNEPrice History

VYNE logoVYNE Therapeutics Inc. (VYNE) Stock Price History

Historical prices from 2018 to 2026

$39.50+3.08  (+8.46%)close Aug 24
Returns
1M
—
3M
+21.5%
YTD
+36.3%
1Y
+83.7%
3Y
-38.6%
5Y
-48.7%
ATH$143,496.00Feb 2018-100.0%
ATL$14.03Sep 2025pre-split
Avg Vol (50D)31K/ day
52-Week Range$16.04 — $46.95
LowCurrent: $39.50High

Loading 10-year price history...

VYNE Historical Performance

1 YearTotal Return
+179.1%
Price: +83.7%Div: +95.4%
3 YearsTotal Return
-64.8%
CAGR: -29.4%
Price: -76.8%
5 YearsTotal Return
-94.6%
CAGR: -44.3%
Price: -96.5%
YTD
+36.3%

VYNE Annual Returns

Year-by-year price performance · 2018–2026

Best+46.9%2024
Worst-86.7%2022
Up years1/9
2018-85.6%
2019-3.9%
2020-63.3%
2021-84.3%
2022-86.7%
2023-5.7%
2024+46.9%
2025-82.6%
2026-1.5%
2018 annual price return
-85.6%
2019 annual price return
-3.9%
2020 annual price return
-63.3%
2021 annual price return
-84.3%
2022 annual price return
-86.7%
2023 annual price return
-5.7%
2024 annual price return
+46.9%
2025 annual price return
-82.6%
2026 annual price return
-1.5%
LessMore
Alpha vs S&P 500
1Y+164.1%
3Y-51.8%
5Y-56.2%

Price returns only.

Download Historical Data

2,156 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

VYNE Stock Price Trajectory (2018–2026)

As of October 10, 2026, VYNE Therapeutics Inc. (VYNE) trades at $39.50, representing a +83.7% return over the past year. The stock has delivered a -94.6% total return over five years (-48.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $143,496.00 on February 6, 2018. From this peak, VYNE has corrected -100.0%, currently trading 31% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers DERM (-20.9% 1Y), PRGO (-33.0% 1Y), and SKIN (-66.5% 1Y), VYNE has outperformed the peer group average. Compare VYNE vs DERM →

VYNE Historical Price Data · from 2018

Rows 1–50 of 2,156
Date Open High Low Close Volume Change %
2026-08-2438.2841.8136.5339.50207K+8.46%
2026-08-2137.0038.3835.5036.4226K-4.66%
2026-08-2040.0040.0037.6038.2022K-5.91%
2026-08-1942.9842.9839.1040.6034K-2.22%
2026-08-1841.9242.4840.9441.5218K+0.29%
2026-08-1742.8943.0041.1041.4015K-2.57%
2026-08-1442.5142.8641.9042.495K-0.54%
2026-08-1343.0644.2641.1142.7214K-0.12%
2026-08-1243.8944.0041.7342.7711K-0.40%
2026-08-1142.0142.9441.6742.945K+2.31%
2026-08-1041.5742.2940.2041.9723K+1.30%
2026-08-0742.0644.2841.1241.4324K-0.50%
2026-08-0637.0242.5037.0241.6419K+10.45%
2026-08-0539.0039.3537.4837.7026K-0.68%
2026-08-0434.4439.9934.4437.9640K+13.01%
2026-08-0335.5537.1532.3933.5916K-4.08%
2026-07-3134.7935.9631.5535.0218K+6.15%
2026-07-3030.0934.3529.8032.9922K+8.34%
2026-07-2928.0032.1027.5530.4516K+8.56%
2026-07-2828.9428.9426.4728.0528K-1.79%
2026-07-2725.5028.5623.3728.5693K+12.22%
2026-07-2424.3427.4423.5025.4559K-44.88%
2026-07-2343.7246.9540.9146.1720K+2.87%
2026-07-2242.7645.5042.5044.8824K+0.54%
2026-07-2139.2044.9538.9044.64108K+10.52%
2026-07-2038.5040.8737.7540.3945K+6.15%
2026-07-1738.0039.0037.0638.0520K-0.86%
2026-07-1637.3439.4837.2738.3831K+1.37%
2026-07-1535.8038.7435.8037.8644K+6.50%
2026-07-1432.5036.0032.5035.5529K+8.05%
2026-07-1331.7534.6031.7532.9059K+3.20%
2026-07-1031.2632.9130.6231.88322K-5.12%
2026-07-0932.3333.9532.3333.60542+3.35%
2026-07-0832.5133.3331.6632.51443-2.93%
2026-07-0733.2033.5032.4033.491K+0.33%
2026-07-0634.2334.2332.5733.382K-1.79%
2026-07-0234.0034.4933.5033.9910K-0.18%
2026-07-0132.5034.7432.5034.0514K+4.67%
2026-06-3032.6233.1232.3532.531K+0.46%
2026-06-2932.0033.0031.5032.382K-0.12%
2026-06-2631.6233.0731.1832.422K-0.49%
2026-06-2531.1833.1331.1832.582K+0.15%
2026-06-2433.0033.8332.5332.533K+0.09%
2026-06-2332.2532.7532.2532.507710.00%
2026-06-2232.1432.9532.0132.50908+2.30%
2026-06-1831.3433.0531.1631.775K+0.67%
2026-06-1732.0932.5031.1631.56510-0.28%
2026-06-1630.5132.5030.5131.652K+1.77%
2026-06-1532.4532.8930.5031.1011K-4.07%
2026-06-1233.2533.2532.2632.422K-2.50%
…
Consensus & Technical Research Suite
Open VYNE Terminal

VYNE Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

VYNE — Frequently Asked Questions

Quick answers to the most common questions about buying VYNE stock.

How has VYNE stock performed recently?

VYNE returned +83.7% over the past year, beating its 5-year annualized CAGR of -48.7%. The stock trades above its 200-day moving average, confirming the uptrend.

What is VYNE's all-time high price?

VYNE Therapeutics Inc. reached $143496.00 on 2018-02-06. The 52-week high is $46.95. Current 1-year return of +83.7% places the stock closer to historical peaks.

Where can I download VYNE historical price data?

This page provides VYNE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.

432 data points · sampled from 2,156